NovaSignal
NovaSignal was a Los Angeles-based medical technology company that developed NovaGuide, an AI-powered robotic cerebral ultrasound system for non-invasive cerebral blood flow assessment targeting stroke and neurological condition diagnosis at hospitals and healthcare providers.
- Company typePrivate
- Founded2013
- HeadquartersLos Angeles, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What NovaSignal does
NovaSignal was a medical technology company founded in 2013 and headquartered in Los Angeles, California, that developed and commercialized AI-powered diagnostic technology for stroke and neurological conditions. The company's core product was NovaGuide, a robotic cerebral ultrasound system designed for non-invasive cerebral blood flow assessment, intended to enable healthcare providers to detect stroke and other neurological conditions more rapidly and accurately in clinical settings. NovaSignal pursued a vertical go-to-market focused exclusively on healthcare providers and hospitals, distributing its hardware devices through a direct enterprise field sales motion, supplemented by participation in medical technology conferences and industry publications.
The company funded its development through an extensive capital-raising program, completing approximately fifteen funding rounds between 2013 and 2021 that collectively raised roughly $126 million, including a $37 million Series C1 in September 2021 led by Alpha Edison and Reimagined Ventures, a $22 million Series C in 2019 led by Alpha Edison, and earlier rounds involving TCA Venture Group, JSR Limited, Tigermed, Taiyu Capital, UCLA Ventures, and non-dilutive grants from the National Institutes of Health and National Science Foundation. Revenue was generated through hardware sales of the NovaGuide diagnostic device to hospitals, with no pricing details publicly disclosed. In 2023, NeuraSignal, Inc. acquired NovaSignal's business operations, including the NovaGuide platform, and the original NovaSignal entity ceased to operate as an independent company.
NovaSignal firmographics
Firmographics- Name
- NovaSignal
- Legal name
- NovaSignal Corp.
- Website
- https://novasignal.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Acquired
- Headcount range
- 51–100 employees
- Short description
- NovaSignal was a Los Angeles-based medical technology company that developed NovaGuide, an AI-powered robotic cerebral ultrasound system for non-invasive cerebral blood flow assessment targeting stroke and neurological condition diagnosis at hospitals and healthcare providers.
- Ownership category
- akta.pro rank
NovaSignal industry classification
Industry- Product category
- Neurological Diagnostic Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear) (HLAKABAE)
Keywords
Where NovaSignal is headquartered
LocationHeadquarters
- HQ city
- Los Angeles
- HQ country
- United States
- HQ region
- North America
Markets served
NovaSignal business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Marketing or Sales, Operations
Revenue model
- Medical Device and Diagnostic Services: Revenue generated from AI-powered medical diagnostic devices and related services for stroke and neurological conditions. The company develops and commercializes medical technology products targeting healthcare providers and hospitals.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
NovaSignal product offering
Product offeringCore offering
NovaSignal developed and commercialized NovaGuide, a medical ultrasound device for non-invasive cerebral blood flow assessment. Healthcare providers and hospitals used it to detect, assess, and monitor stroke and other neurological conditions. NeuraSignal, Inc. acquired the business in 2023.
Differentiator
Problem solved
Functional benefit
Brands
- NovaGuide: The original technology platform developed by NovaSignal for stroke and neurological condition diagnosis.
Products and services
- NovaGuide Medical ultrasound device for non-invasive cerebral blood flow assessment used in stroke and neurological condition detection, assessment, and monitoring.
Quantifiable outcome
- Improved diagnostic accuracy for stroke detection
Companies that use NovaSignal
Customer profileSegments1 record
Ideal customer profiles1 record
NovaSignal technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
NovaSignal partnerships and signals
Strategic signalScale indicators2 records
Recent moves7 records
Expansion highlights5 records
NovaSignal competitors and assessment
Company assessmentDirect peers
- Viz.ai: Viz.ai provides AI-powered clinical workflow and imaging solutions for stroke detection and care coordination, competing directly with NovaSignal in AI-enabled stroke diagnostics. Both target the same hospital neurology and emergency medicine buyers with AI-driven clinical decision support.
- RapidAI: RapidAI (formerly iSchemaView) offers AI-powered imaging analysis for stroke and other neurological conditions via the RAPID platform for CT and MRI perfusion. Both RapidAI and NovaSignal apply AI to accelerate and improve stroke diagnosis in hospital settings.
- Cadwell Industries: Cadwell manufactures neurodiagnostic equipment including transcranial Doppler systems used in hospital and clinical neurology settings. As a specialized neurodiagnostic device maker, Cadwell directly competes with NovaSignal in TCD and cerebral blood flow assessment.
- Neural Analytics: Neural Analytics developed a robotic transcranial Doppler platform (Lucid System) for cerebral blood flow assessment in stroke and other neurological conditions, making it the most direct technology peer to NovaSignal's NovaGuide platform before both companies evolved through acquisitions.
Broad incumbents
- Siemens Healthineers: Siemens Healthineers offers a comprehensive imaging portfolio including ultrasound, CT, and MRI used in stroke diagnosis and neurological assessment. As a broad incumbent, it competes indirectly across multiple hospital imaging modalities relevant to NovaSignal's addressable market.
- GE HealthCare: GE HealthCare is a major medical imaging incumbent with a broad portfolio of ultrasound systems, including vascular and point-of-care ultrasound used in neurology and emergency settings. Its installed base and R&D resources make it a powerful indirect competitor in cerebral ultrasound.
- Penumbra: Penumbra is a larger neurovascular company with a portfolio of stroke treatment and imaging products, including the REAL Immersive System for cerebral imaging. While broader than NovaSignal, Penumbra operates in overlapping stroke and neurovascular hospital channels.
- Natus Medical: Natus Medical manufactures neurodiagnostic and monitoring equipment used in hospitals and clinical settings, including transcranial Doppler and neurology monitoring products. It is a broader incumbent in the neurodiagnostic device category where NovaSignal competes.
- Compumedics: Compumedics designs and manufactures diagnostic devices for neurology, sleep, and brain research, including ultrasound-based blood flow measurement products. It is a broader neurodiagnostic device incumbent with overlapping technology and customer base.
Emerging players
- BrainScope: BrainScope develops AI-powered, non-invasive brain injury assessment devices for concussion and mild traumatic brain injury in emergency and clinical settings. It is an emerging player with overlapping AI-driven neurological diagnostics but a different primary clinical use case than stroke.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks4 records
Key highlights5 records
Customer concentration
NovaSignal social profiles
Digital presenceNovaSignal financial estimates
Financial estimateRevenue estimate
Valuation estimate
NovaSignal leadership team
Management profileNumber of profiles
NovaSignal funding detail
Funding detailFunding overview
Funding rounds15 records
Investors13 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NovaSignal M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NovaSignal
What does NovaSignal do?
NovaSignal developed and commercialized NovaGuide, a medical ultrasound device for non-invasive cerebral blood flow assessment. Healthcare providers and hospitals used it to detect, assess, and monitor stroke and other neurological conditions. NeuraSignal, Inc. acquired the business in 2023.
Is NovaSignal a public or private company?
NovaSignal is a private company. It is classified as corporate owned and is currently acquired.
When was NovaSignal founded?
NovaSignal was founded in 2013. It employs 51 to 100 people.
Where is NovaSignal based?
NovaSignal is headquartered in Los Angeles, United States, in the North America region.
How does NovaSignal make money?
One revenue line is on record: medical Device and Diagnostic Services.
Who are NovaSignal's main competitors?
Direct peers on record are Viz.ai, RapidAI, Cadwell Industries and Neural Analytics. Broad incumbents are Siemens Healthineers, GE HealthCare, Penumbra, Natus Medical and Compumedics. BrainScope is listed as an emerging player.
Does NovaSignal have an API?
No public API is recorded for NovaSignal.
What industry is NovaSignal in?
NovaSignal's product category is Neurological Diagnostic Devices. Its primary akta.pro industry code is HLAKABAE, Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear). Its NAICS code is 339112 and its SIC code is 3841.